Please use this search facility to search all content found within the website:

244 results:

GForte_EMP_Strategy_2030_ihp__meeting_v2.pdf

GForte_EMP_Strategy_2030_ihp__meeting_v2.pdf

…TOWARDS ACCESS 2030 WHO Medicines and Health Products Programme Strategic Framework 2016 - 2030 HIS/EMP| |April Communications Planning WHO/HIS/EMP 3, 2017 What guides us HIS/EMP| |April Communications Planning…

Handout_Knowledge_gap_nr._1.Pharmaceuticals.pdf

Handout_Knowledge_gap_nr._1.Pharmaceuticals.pdf

… these markets appealing to indigenous and international criminal rings. In fact, the smuggling of medicines across borders and frontline is a cornerstone of the war economy. Such murky businesses are poorly…

Preventing antimicrobial resistance together: why we should leverage universal health coverage to address AMR

Preventing antimicrobial resistance together: why we should leverage universal health coverage to address AMR

… death. Antimicrobials - including antibiotics, antivirals, antifungals and antiparasitics - are medicines used to prevent and treat infections in humans, animals, and plants. Left unchecked, AMR will roll…

How to move towards universal health coverage in crisis-affected settings: lessons from research

… quality essential healthcare services and access to safe, effective, quality and affordable essential medicines and vaccines for all’. This policy brief reviews the meaning of UHC and summarises lessons for…

Ex Team NFR.28jun12

ExTeam NFR.28jun12.pdf

… Kingdom (DfID), WB, WHO. ACTIONS:  Harmonization of quality assurance of donor-procured essential medicines will be a topic of discussion at the country teams meeting.  Rwanda JANS: the team will share the…

VNR_Lab_SDG3_WHO.pdf

VNR_Lab_SDG3_WHO.pdf

… 2023 with quality essential health services and quality, safe, effective, affordable and essential medicines, vaccines, diagnostics and health technologies, with a view to covering all people by 2030; (b) To…

Private_Sector_Membership_Agreements.pdf

Private_Sector_Membership_Agreements.pdf

… below). Core Action Group of the UHC2030 Private Sector Constituency Example: Composition of the Medicines Group Health Value Chain (2 seats) Disruptive Technology (2 seats) Health Insurance (6 seats) …

Session9a_Procurement_IanPett.pptx

Session9a_Procurement_IanPett.pptx

… Women’s and Children’s Health . World Bank HNP Discussion Paper: Assuring the Quality of Essential Medicines Procured with Donor Funds and Draft Harmonized Assessment Tool based on the Model Quality…

Session_2.2_UHC2030_-_for_IHP_GSchmets.pptx

Session_2.2_UHC2030_-_for_IHP_GSchmets.pptx

… Health Service Delivery Networks Capacity building with emphasis on primary care. Essential medicines & technologies selection for PHC Strengthen supply and delivery of essential medicines Paraguay…

Joint Statement by the UHC2030 Private Sector Constituency

Joint Statement by the UHC2030 Private Sector Constituency

… care (including self-care), immunization at all ages, early diagnosis, and treatment with quality medicines -- all underpinned by strong primary health care. The private sector is an engine for innovation…